MOH Chart

1 Month

	Date	Diff
	2025-04-23	+3.38 %
Molina Healthcare (MOH) stock rose by 3.38%, attributed to positive investor sentiment following an increase in price target ratings from several analysts, despite the company's recent earnings miss. Molina Healthcare (MOH) stock rose 3.38% likely due to the optimism surrounding President Trump's potential policy changes, including signals about reducing tariffs on imports, which could positively impact the healthcare and pharmaceutical industries.
	2025-04-21	-6.24 %
Molina Healthcare (MOH) stock fell by 6.24% as investors reacted to the company's previous earnings report that missed analyst expectations, and ahead of an upcoming earnings announcement where lower-than-expected future earnings could further impact investor sentiment. Molina Healthcare (MOH) stock fell by 6.24% recently, largely due to decreased institutional investment, with XTX Topco Ltd significantly lowering its stake and other large investors also changing their positions, alongside mixed analyst ratings and a disappointing earnings report that fell short of expectations.
	2025-04-17	-3.07 %
Molina Healthcare (MOH) stock fell by 3.07% after being downgraded from a "strong-buy" to a "hold" rating by Baird R W, while other research firms made mixed adjustments to their price targets and ratings.
	2025-04-16	-0.93 %
Molina Healthcare (MOH) stock dipped by 0.93% last night, despite having historically outperformed the market with an average annual return of 12.85% over the past two decades, possibly due to market fluctuations or investor reactions to recent financial performance or news affecting the healthcare sector.
	2025-04-14	+1.03 %
Molina Healthcare (NYSE:MOH) stock increased by 1.03% following Truist Financial's upgrade of its target price from $340.00 to $400.00, along with positive ratings and target adjustments from several other analysts, indicating investor confidence in the company's future performance.
	2025-04-08	-2.86 %
Molina Healthcare, Inc. (NYSE:MOH) shares experienced a decline of 2.86%, attributed to several downgrades by analysts, including a recent cut from "buy" to "hold" by StockNews.com and lower price targets set by UBS and Truist Financial, indicating concerns about the company's performance.
	2025-04-07	-1.83 %
Molina Healthcare (MOH) stock declined by 1.83% following a quarterly earnings report that missed analysts' expectations, along with some analysts revising their target prices downward.
	2025-04-04	-1.85 %
Molina Healthcare (MOH) stock fell by 1.85% after StockNews.com downgraded its rating from buy to hold, amidst mixed ratings from several brokerages regarding its future price targets and performance. Molina Healthcare (MOH) stock was down 1.85% amid a broader market slump driven by concerns over an escalating trade war impacting corporate profits and consumer spending. The decline in MOH could be attributed to the overall negative market sentiment, despite healthcare being generally considered a safer investment during economic downturns. Molina Healthcare (MOH) stock experienced a decline of -1.85% amidst a broader stock market slump influenced by concerns over an escalating trade war, which is expected to negatively impact corporate profits and consumer spending. The drop in Molina Healthcare's stock may be related to overall market volatility affecting investor sentiment, despite the healthcare sector's relative resilience during economic downturns. Molina Healthcare (MOH) stock declined by -1.85% amidst a broader market slump driven by concerns over an escalating trade war, reflecting investor caution despite the healthcare sector's general resilience during economic downturns.
	2025-03-31	+2.03 %
Molina Healthcare (MOH) stock rose by 2.03% following significant changes in institutional investor holdings, including a 19.6% reduction by Corebridge Financial, and positive adjustments in analysts' ratings, with several rating the stock as a "buy" despite recent earnings miss. The increase in Molina Healthcare (MOH) stock may be attributed to optimistic analyst ratings and increased institutional investment, signaling confidence in the company's performance potential.
	2025-03-28	-0.19 %
Molina Healthcare (MOH) stock fell by 0.19% despite receiving an upgrade to a "buy" rating from StockNews.com, as analysts have lowered price targets and the company reported earnings that missed expectations. The decline in the stock price can be attributed to analysts reducing their price objectives and the company's recent earnings miss, which may have raised concerns among investors.
	2025-03-18	+0.35 %
Molina Healthcare (MOH) stock rose by 0.35% following increased institutional investment, including a 10% stake increase by PNC Financial Services Group, signaling growing confidence in the company’s performance.
	2025-03-14	-0.92 %
Molina Healthcare (MOH) shares declined 0.92% after a combination of analysts reducing their price targets and a disappointing earnings report, which saw the company miss earnings estimates by $0.69.
	2025-03-12	-3.03 %
Molina Healthcare (MOH) stock decreased by 3.03% last night despite its historical outperformance of the market, largely due to factors such as market volatility or investor sentiment that can negatively impact share prices. Molina Healthcare (NYSE:MOH) stock fell by 3.03% following a downgrade from a “buy” rating to a “hold” rating by StockNews.com and a reduction in target prices by multiple research firms after the company reported earnings that missed analysts' expectations.
	2025-03-07	+1.08 %
Molina Healthcare (MOH) stock increased by 1.08% following institutional investors adjusting their holdings and positive analyst ratings, despite some price target reductions. The rise in stock price may be attributed to a mix of institutional investment activity, including QRG Capital Management's significant reduction and other firms increasing stakes, alongside analysts maintaining mostly favorable ratings on the stock despite some target price adjustments. Molina Healthcare (NYSE: MOH) stock rose 1.08% after Wells Fargo upgraded its rating from "equal weight" to "overweight," significantly increasing its price target from $295.00 to $372.00, indicating potential upside for investors.
	2025-03-05	+1.76 %
Molina Healthcare (NYSE: MOH) stock rose by 1.76% following the announcement of President & CEO Joseph M Zubretsky's insider purchase of 65,487 shares, which suggests confidence in the company's future performance. Molina Healthcare (MOH) stock rose by 1.76% following the disclosure of an insider purchase by Chief Legal Officer Jeff D. Barlow, who bought 12,741 shares, suggesting confidence in the company’s future performance. Molina Healthcare (MOH) stock rose by 1.76% following a significant insider purchase of 9,659 shares by Debra Bacon, the EVP, indicating strong confidence in the company's future performance. Molina Healthcare (MOH) stock rose 1.76% following Chief Financial Officer Mark Lowell Keim's insider purchase, which was disclosed in a recent SEC filing, indicating confidence in the company's future performance. Molina Healthcare (MOH) stock rose by 1.76% following the insider purchase of 15,564 shares by COO James Woys, reflecting his confidence in the company's future performance.
	2025-02-20	+1.63 %
Molina Healthcare (MOH) stock increased by 1.63% due to various institutional investors adjusting their positions, highlighting strong interest and potential confidence in the company's long-term viability, despite recent earnings results that missed analyst expectations.
	2025-02-18	-1.37 %
Molina Healthcare's (MOH) stock fell by 1.37% following a quarterly earnings report that showed earnings per share of $5.05, which missed the consensus estimate of $5.74, coupled with several analysts lowering their price targets for the stock.
	2025-02-10	+0.86 %
Molina Healthcare (MOH) stock increased by 0.86% amidst mixed analyst ratings, with a recent downgrade from "strong-buy" to "buy" by StockNews.com, alongside varied price targets from several investment firms following a disappointing quarterly earnings report. The stock appears to have benefitted from increased interest from hedge funds, which could indicate growing institutional support.
	2025-02-07	-0.36 %
Molina Healthcare's (MOH) stock fell by -0.36% to $294.10 after a disappointing earnings report, where the company reported a quarterly EPS of $5.05, missing expectations by $0.69.
	2025-02-05	+0.51 %
Molina Healthcare (MOH) stock rose by 0.51% due to increased institutional investment, particularly by Caprock Group LLC, which boosted its stake by 18.1%, as well as positive ratings from several equity analysts suggesting strong future performance. Molina Healthcare (MOH) stock rose by 0.51% due to increased investments from institutional investors like Blue Trust Inc., which raised its holdings by 35.5%, indicating growing confidence in the company's prospects. Molina Healthcare (MOH) stock rose by 0.51% due to increased institutional investment, including significant purchases and holdings adjustments by several hedge funds during the fourth quarter.
	2025-02-04	-3.06 %
Molina Healthcare (MOH) stock decreased by 3.06% due to a mix of modest price target adjustments from various analysts, including a downgrade by Robert W. Baird, signaling potential concerns over the company's valuation and performance expectations. Molina Healthcare (MOH) stock declined by 3.06% as it approaches the release of its quarterly earnings results, which has led to analysts adjusting their price targets and ratings, potentially impacting investor sentiment and stock performance.
	2025-02-03	+4.82 %
Molina Healthcare (MOH) stock rose by 4.82% after StockNews.com upgraded its rating from buy to strong-buy, indicating positive analyst sentiment, while other reports raised price targets for the stock, suggesting strong investor confidence.
	2025-01-31	-0.79 %
Molina Healthcare (MOH) stock experienced a decline of 0.79% last night, despite its impressive 144% increase over the past five years; the downturn may be attributed to overall investor sentiment and a challenging year where the company faced a 12% loss against a broader market gain of 26%.
	2025-01-30	+2.83 %
Molina Healthcare's stock (MOH) rose by 2.83% due to increased institutional investment, with Fifth Third Bancorp boosting its stake significantly and other hedge funds also acquiring shares, reflecting positive market sentiment despite mixed ratings from research analysts.
	2025-01-27	+2.48 %
Molina Healthcare (NYSE: MOH) stock increased by 2.48% following Nisa Investment Advisors LLC's 4.0% growth in holdings, alongside several other institutional investors raising their stakes in the company.
	2025-01-23	+1.22 %
Molina Healthcare (MOH) stock rose by 1.22% last night, driven by a positive consensus among analysts, with several raising their price targets and a recent earnings report that exceeded expectations. Molina Healthcare (MOH) stock rose 1.22% following Cantor Fitzgerald's bullish FY2025 earnings estimate of $26.35 per share and an "Overweight" rating with a target price of $406.00, signaling positive investor sentiment towards the company's performance and growth prospects.
	2025-01-22	+1.76 %
Molina Healthcare (MOH) stock rose 1.76% following positive earnings results that exceeded analysts' expectations and ongoing investor confidence reflected in various adjustments to institutional holdings and analyst ratings. The increase in MOH stock can be attributed to better-than-expected earnings per share and revenue growth, which highlighted the company's strong financial performance and optimistic outlook among analysts.
	2025-01-17	+1.28 %
Molina Healthcare (NYSE:MOH) stock rose by 1.28% following increased institutional investment, particularly from firms like Wealth Enhancement Advisory Services LLC and AQR Capital Management LLC, which have significantly boosted their stakes in the company.
	2025-01-06	+1.3 %
Molina Healthcare's stock (NYSE: MOH) rose by 1.3% following the market's positive reaction to various analysts' ratings and price target adjustments, including a maintained "buy" rating from Truist Financial, despite a decrease in their price target suggestion, indicating investor confidence in the company's growth potential.
	2024-12-04	-0.51 %
Molina Healthcare's stock (MOH) fell by 0.51%, receiving a consensus "Hold" rating from analysts, partly due to a recent downgrade from Robert W. Baird from $405.00 to $331.00 in their target price.
	2024-11-25	+2.47 %
Molina Healthcare (MOH) stock rose by 2.47% last night, largely due to the company reporting better-than-expected earnings and revenue, beating analyst estimates, while strong institutional investor interest also supported the stock's upward movement.
	2024-11-19	-3.32 %
Molina Healthcare's (NYSE: MOH) stock fell by 3.32% amid recent adjustments in analysts' price targets and ratings, indicating potential market uncertainty about its future performance despite strong quarterly earnings. The stock's decline may be attributed to mixed analyst ratings and downward revisions of price targets, which could have influenced investor sentiment negatively.
	2024-11-18	-0.73 %
Molina Healthcare (MOH) stock fell by 0.73% following a downgrade in FY2024 earnings per share estimates by Zacks Research, which revised its forecast from $23.64 to $23.53, leading to a negative sentiment among investors.
	2024-11-14	-1.07 %
Michael Burry increased his investments in Molina Healthcare among other stocks, but the stock has recently declined by 1.07% likely due to broader market concerns and investor sentiment influenced by Burry's bearish options strategies.
	2024-11-13	-3.01 %
Molina Healthcare (MOH) stock fell by 3.01%, likely due to mixed reactions from analysts regarding its recent earnings performance, alongside significant insider selling, and adjustments in price targets by various research firms.
	2024-11-07	+3.52 %
Molina Healthcare (MOH) stock rose by 3.52% due to strong earnings results that surpassed expectations, with the company reporting earnings per share of $6.01 against an anticipated $5.96 and revenue of $10.34 billion, which was higher than the expected $9.92 billion. Molina Healthcare (NYSE: MOH) stock rose by 3.52% due to increased institutional investment, as evidenced by the National Pension Service growing its stake and several other funds acquiring new positions, along with favorable earnings results that exceeded analysts' expectations.
	2024-11-01	+1.72 %
Molina Healthcare (MOH) stock rose by 1.72% due to increased investment activity from large institutional investors and positive analyst ratings following a strong quarterly earnings report that exceeded revenue forecasts and demonstrated significant year-over-year growth.
	2024-10-30	+0.33 %
Molina Healthcare (MOH) stock rose by 0.33% despite Forsta AP Fonden reducing its position in the company by 17.4%, indicating potential investor confidence or positive market sentiment surrounding the stock.
	2024-10-29	+2.52 %
Molina Healthcare (MOH) stock rose 2.52% due to DekaBank Deutsche Girozentrale increasing its position in the company by 2.2%, reflecting positive investor sentiment. Molina Healthcare (MOH) stock rose by 2.52% following a strong earnings report, where it exceeded earnings and revenue projections, leading to positive analyst ratings and increased interest from institutional investors.
	2024-10-28	-3.18 %
Molina Healthcare (MOH) stock fell by 3.18% last night following analysts' price target reductions and mixed ratings from various firms, despite a recent earnings report that beat estimates. Molina Healthcare (MOH) stock fell by 3.18% following recent earnings results that, despite beating consensus estimates, may not have met investor expectations, compounded by analysts' mixed views on price targets and ratings. Molina Healthcare's stock (NYSE: MOH) fell by 3.18% after Raymond James & Associates increased its stake in the company by 59.9% during the third quarter, indicating potential investor concern or market reaction to institutional investment changes.
	2024-10-25	+0.6 %
Molina Healthcare (MOH) stock rose by 0.6% following Barclays' report increasing its price target from $359.00 to $372.00 and maintaining an "equal weight" rating, indicating positive sentiment among analysts.